Jeremy R. Graff
- Molecular Biology top 0.2%
- PI3K/AKT/mTOR signaling in cancer 15
- Cancer-related gene regulation 12
- Epigenetics and DNA Methylation 12
- Polyamine Metabolism and Applications 9
- RNA and protein synthesis mechanisms 6
- Cancer Research top 0.5%
- Pathology and Forensic Medicine top 0.5%
- Oncology top 0.5%
- Genetics top 1%
-
- Cancer Research and Treatments 15
-
- Immune cells in cancer 11
-
- Antifungal resistance and susceptibility 7
- Co-authors
- James G. HermanSanna MyöhänenS B BaylinB D NelkinJean‐Pierre J. IssaPaula M. VertinoStephen B. BaylinArrigo De Benedetti
- Journals
- Cancer Research (22 papers)Cancer Immunology Research (5 papers)International Journal of Cancer (4 papers)
- Partner nations
- United StatesCanadaSingapore
In The Last Decade
Jeremy R. Graff
84 papers receiving 14.4k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Molecular Biology 12.0k
- Cancer Research 2.6k
- Pathology and Forensic Medicine 2.2k
- Oncology 3.2k
- Genetics 1.6k
Countries citing papers authored by Jeremy R. Graff
This map shows the geographic impact of Jeremy R. Graff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeremy R. Graff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeremy R. Graff more than expected).
Fields of papers citing papers by Jeremy R. Graff
This network shows the impact of papers produced by Jeremy R. Graff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeremy R. Graff. The network helps show where Jeremy R. Graff may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jeremy R. Graff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 37 | |
| 2 | 2016 | 6 | |
| 3 | 2016 | 37 | |
| 4 | 2015 | 27 | |
| 5 | 2014 | 151 | |
| 6 | 2009 | 156 | |
| 7 | 2008 | 40 | |
| 8 | Alternative Splicing of a Cancer-Associated Intronic Variant of TG-FBR1 in Cancer Cell Lines | 2006 | 1 |
| 9 | 2006 | 38 | |
| 10 | eIF-4E expression and its role in malignancies and metastasesbreakdown → | 2004 | 600 |
| 11 | 2004 | 17 | |
| 12 | 2004 | 35 | |
| 13 | 2003 | 179 | |
| 14 | 2002 | 54 | |
| 15 | Integrin-linked kinase expression increases with prostate tumor grade. | 2001 | 115 |
| 16 | 2000 | 320 | |
| 17 | 1998 | 195 | |
| 18 | 1997 | 286 | |
| 19 | Alterations in DNA Methylation: A Fundamental Aspect of Neoplasiabreakdown → | 1997 | 1640 |
| 20 | 1997 | 38 |
About Jeremy R. Graff
Jeremy R. Graff is a scholar working on Biotechnology, Immunology and Oncology, having authored 84 papers that have together received 14.7k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (15 papers), Cancer Research and Treatments (15 papers), Cancer-related gene regulation (12 papers), Epigenetics and DNA Methylation (12 papers), Immune cells in cancer (11 papers), Polyamine Metabolism and Applications (9 papers), Antifungal resistance and susceptibility (7 papers) and RNA and protein synthesis mechanisms (6 papers). The work is most often cited by research in Molecular Biology (12.0k citations), Cancer Research (2.6k citations) and Pathology and Forensic Medicine (2.2k citations). Jeremy R. Graff has collaborated with scholars based in United States, Canada and Singapore. Frequent co-authors include James G. Herman, Sanna Myöhänen, S B Baylin, B D Nelkin, Jean‐Pierre J. Issa, Paula M. Vertino, Stephen B. Baylin, Arrigo De Benedetti, Bruce W. Konicek and Julia H. Carter. Their work appears in journals such as Cancer Research, Cancer Immunology Research, International Journal of Cancer, The Journal of Immunology and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.